Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Calamine** is a topical over-the-counter inorganic skin protectant and astringent material, conventionally consisting predominantly of zinc oxide with a small amount of ferric oxide that gives the material its characteristic pink color. It is used in topical preparations to temporarily relieve itching and minor skin irritation, including irritation associated with poison ivy, poison oak, poison sumac, and insect bites, and to help dry oozing or weeping skin. Its effect is local and physical rather than mediated through a defined molecular receptor target. U.S. OTC regulations list calamine as an allowable skin-protectant active ingredient at concentrations of 1% to 25%. ([ecfr.gov](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-347/subpart-B/section-347.10))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calamine.